Halozyme Therapeutics, Inc.HALONASDAQ
Loading
Pre-Tax Margin Over TimeContracting
Percentile Rank64
3Y CAGR-3.9%
5Y CAGR-7.1%
Studio
Year-over-Year Change

Pre-tax income as a percentage of revenue

3Y CAGR
-3.9%/yr
Annual compound
5Y CAGR
-7.1%/yr
Recent acceleration
Percentile
P64
Within normal range
vs 5Y Ago
0.7x
Contraction
Streak
1 yr
Consecutive declineContracting
PeriodValueYoY Change
TTM33.43%-39.1%
202454.87%+30.6%
202342.01%+11.4%
202237.71%-32.7%
202156.06%+16.0%
202048.32%+231.1%
2019-36.86%+29.8%
2018-52.54%-370.0%
201719.46%+128.0%
2016-69.44%-